A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417)
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
This observational study will explore the Swedish national population of patients with
rheumatoid arthritis (RA) on infliximab maintenance therapy in order to identify patients who
may be eligible for a dose reduction study. Patients will be asked a variety of questions
regarding their treatment dosing and disease activity, and then asked whether or not they
would consider participating in a dose reduction study. Patients in this study will be
described in terms of demographic and disease characteristics.